Robert Bona, MD
Professor of Medicine (Hematology); Professor of Medicine, Hematology; Clinical Director, Classical Hematology Program; Medical Director, Hemophilia Treatment Center
Research & Publications
Biography
News
Coauthors
Selected Publications
- Iron Infusion Reactions: Risk Factors and Real-World ExperienceButt A, Muradashvili T, Soliman S, Goshua G, Burns A, Bar N, Martin K, Borgman G, Bona R, Lee A, Neparidze N. Iron Infusion Reactions: Risk Factors and Real-World Experience. Blood 2021, 138: 4154. DOI: 10.1182/blood-2021-151048.
- Intermediate‐dose anticoagulation, aspirin, and in‐hospital mortality in COVID‐19: A propensity score‐matched analysisMeizlish ML, Goshua G, Liu Y, Fine R, Amin K, Chang E, DeFilippo N, Keating C, Liu Y, Mankbadi M, McManus D, Wang SY, Price C, Bona RD, Chaar C, Chun HJ, Pine AB, Rinder HM, Siner JM, Neuberg DS, Owusu KA, Lee AI. Intermediate‐dose anticoagulation, aspirin, and in‐hospital mortality in COVID‐19: A propensity score‐matched analysis. American Journal Of Hematology 2021, 96: 471-479. PMID: 33476420, PMCID: PMC8013588, DOI: 10.1002/ajh.26102.
- Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional studyGoshua G, Pine AB, Meizlish ML, Chang CH, Zhang H, Bahel P, Baluha A, Bar N, Bona RD, Burns AJ, Dela Cruz CS, Dumont A, Halene S, Hwa J, Koff J, Menninger H, Neparidze N, Price C, Siner JM, Tormey C, Rinder HM, Chun HJ, Lee AI. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. The Lancet Haematology 2020, 7: e575-e582. PMID: 32619411, PMCID: PMC7326446, DOI: 10.1016/s2352-3026(20)30216-7.
- COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms.Malone RW, Tisdall P, Fremont-Smith P, Liu Y, Huang XP, White KM, Miorin L, Olmo EMD, Alon A, Delaforge E, Hennecker CD, Wang G, Pottel J, Bona R, Smith N, Hall JM, Shapiro G, Clark H, Mittermaier A, Kruse AC, García-Sastre A, Roth BL, Glasspool-Malone J, Francone V, Hertzog N, Fremont-Smith M, Ricke DO. COVID-19: Famotidine, Histamine, Mast Cells, and Mechanisms. Research Square 2020 PMID: 32702719, PMCID: PMC7336703, DOI: 10.21203/rs.3.rs-30934/v2.
- Mild macrocytosis in Williams-Beuren syndrome.Yu E, Feinn R, Bona R, Brink B, Sindhar S, Kozel BA, Pober BR. Mild macrocytosis in Williams-Beuren syndrome. European Journal Of Medical Genetics 2020, 63: 103740. PMID: 31419598, DOI: 10.1016/j.ejmg.2019.103740.
- Venous Thromboembolism (VTE) Education Preferences Amongst Physicians and Patients: A Qualitative Needs AssessmentJuthani P, Ahmed D, Ahmed O, Bona R, Neparidze N, Lee A. Venous Thromboembolism (VTE) Education Preferences Amongst Physicians and Patients: A Qualitative Needs Assessment. Blood 2018, 132: 5810. DOI: 10.1182/blood-2018-99-119418.
- Transient bacteremia induced by dental cleaning is not associated with infection of central venous catheters in patients with cancerUsmani S, Choquette L, Bona R, Feinn R, Shahid Z, Lalla RV. Transient bacteremia induced by dental cleaning is not associated with infection of central venous catheters in patients with cancer. Oral Surgery Oral Medicine Oral Pathology And Oral Radiology 2018, 125: 286-294. PMID: 29428697, PMCID: PMC5944361, DOI: 10.1016/j.oooo.2017.12.022.
- Hypercoagulable States: What the Oral Surgeon Needs to Know.Bona R. Hypercoagulable States: What the Oral Surgeon Needs to Know. Oral And Maxillofacial Surgery Clinics Of North America 2016, 28: 491-495. PMID: 27745619, DOI: 10.1016/j.coms.2016.06.002.
- Predictors of warfarin‐associated adverse events in hospitalized patients: Opportunities to prevent patient harmMetersky ML, Eldridge N, Wang Y, Jaser L, Bona R, Eckenrode S, Bakullari A, Andrawis M, Classen D, Krumholz HM. Predictors of warfarin‐associated adverse events in hospitalized patients: Opportunities to prevent patient harm. Journal Of Hospital Medicine 2015, 11: 276-282. PMID: 26662851, DOI: 10.1002/jhm.2528.
- Concurrent polycythemia vera and chronic lymphocytic leukemia: treatment response to pegylated interferon alpha 2a.Selinger HA, Ballesteros E, Bona R. Concurrent polycythemia vera and chronic lymphocytic leukemia: treatment response to pegylated interferon alpha 2a. American Journal Of Hematology 2013, 88: 535-6. PMID: 23553722, DOI: 10.1002/ajh.23449.
- ACP Journal Club: review: factor Xa inhibitors reduce DVT more than LMWH in total knee or hip replacement.Bona R. ACP Journal Club: review: factor Xa inhibitors reduce DVT more than LMWH in total knee or hip replacement. Annals Of Internal Medicine 2012, 157: JC2-5. PMID: 22910959, DOI: 10.7326/0003-4819-157-4-201208210-02005.
- Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Linkins LA, Dans AL, Moores LK, Bona R, Davidson BL, Schulman S, Crowther M. Treatment and prevention of heparin-induced thrombocytopenia: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012, 141: e495S-e530S. PMID: 22315270, PMCID: PMC3278058, DOI: 10.1378/chest.11-2303.
- Severe heart failure after bortezomib treatment in a patient with multiple myeloma: a case report and review of the literature.Bockorny M, Chakravarty S, Schulman P, Bockorny B, Bona R. Severe heart failure after bortezomib treatment in a patient with multiple myeloma: a case report and review of the literature. Acta Haematologica 2012, 128: 244-7. PMID: 22964848, DOI: 10.1159/000340050.
- Heat-shock protein gp96/grp94 is an essential chaperone for the platelet glycoprotein Ib-IX-V complex.Staron M, Wu S, Hong F, Stojanovic A, Du X, Bona R, Liu B, Li Z. Heat-shock protein gp96/grp94 is an essential chaperone for the platelet glycoprotein Ib-IX-V complex. Blood 2011, 117: 7136-44. PMID: 21576699, PMCID: PMC3143555, DOI: 10.1182/blood-2011-01-330464.
- Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation.Bendel SD, Bona R, Baker WL. Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation. Advances In Therapy 2011, 28: 460-72. PMID: 21533567, DOI: 10.1007/s12325-011-0025-1.
- The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1.Usmani SZ, Bona RD, Chiosis G, Li Z. The anti-myeloma activity of a novel purine scaffold HSP90 inhibitor PU-H71 is via inhibition of both HSP90A and HSP90B1. Journal Of Hematology & Oncology 2010, 3: 40. PMID: 20977755, PMCID: PMC2974653, DOI: 10.1186/1756-8722-3-40.
- Folding of Toll-like receptors by the HSP90 paralogue gp96 requires a substrate-specific cochaperone.Liu B, Yang Y, Qiu Z, Staron M, Hong F, Li Y, Wu S, Li Y, Hao B, Bona R, Han D, Li Z. Folding of Toll-like receptors by the HSP90 paralogue gp96 requires a substrate-specific cochaperone. Nature Communications 2010, 1: 79. PMID: 20865800, PMCID: PMC2982182, DOI: 10.1038/ncomms1070.
- Validation and Comparison of Pharmacogenetics-Based Warfarin Dosing Algorithms for Application of Pharmacogenetic TestingRoper N, Storer B, Bona R, Fang M. Validation and Comparison of Pharmacogenetics-Based Warfarin Dosing Algorithms for Application of Pharmacogenetic Testing. Journal Of Molecular Diagnostics 2010, 12: 283-291. PMID: 20228265, PMCID: PMC2860463, DOI: 10.2353/jmoldx.2010.090110.
- 17 AAG for HSP90 inhibition in cancer--from bench to bedside.Usmani SZ, Bona R, Li Z. 17 AAG for HSP90 inhibition in cancer--from bench to bedside. Current Molecular Medicine 2009, 9: 654-64. PMID: 19601813, DOI: 10.2174/156652409788488757.
- A case report of refractory warm autoimmune hemolytic anemia treated with plasmapheresis and rituximab.Aglieco F, Manickaratnam S, Bona R, Kaplan AA. A case report of refractory warm autoimmune hemolytic anemia treated with plasmapheresis and rituximab. Therapeutic Apheresis And Dialysis : Official Peer-reviewed Journal Of The International Society For Apheresis, The Japanese Society For Apheresis, The Japanese Society For Dialysis Therapy 2008, 12: 185-9. PMID: 18387171, DOI: 10.1111/j.1744-9987.2008.00568.x.
- Acquired deficiency of vitamin K-dependent clotting factors due to brodifacoum ingestion.Kapadia P, Bona R. Acquired deficiency of vitamin K-dependent clotting factors due to brodifacoum ingestion. Connecticut Medicine 2008, 72: 207-9. PMID: 18478986.
- A case report of therapeutic leukapheresis in an adult with chronic myelogenous leukemia presenting with hyperleukocytosis and leukostasis.Shafique S, Bona R, Kaplan AA. A case report of therapeutic leukapheresis in an adult with chronic myelogenous leukemia presenting with hyperleukocytosis and leukostasis. Therapeutic Apheresis And Dialysis : Official Peer-reviewed Journal Of The International Society For Apheresis, The Japanese Society For Apheresis, The Japanese Society For Dialysis Therapy 2007, 11: 146-9. PMID: 17381536, DOI: 10.1111/j.1744-9987.2007.00417.x.